MarketPeel
Insider Trading Intelligence
Pricing
…
AW

Adrian Woolfson

SGMO
EVP RESEARCH & DEVELOPMENT · SANGAMO THERAPEUTICS, INC · CIK 0001765497
FILING MIX · LIFETIME100%/0%
BUYS
2
SELLS
0
TOTAL VALUE
$0
COMPANIES
1
ACTIVE SINCE
Feb 2020
HOLDINGS NOW
50,000
AVG SELL PX
—
TRADE KIND
SHOWING 2 / 2
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
No backtest data available for Adrian Woolfson. Backtests are computed for purchase (P) and sale (S) transactions with resolvable price history.
Holdings over time
SGMO · 50,000 shares · as of Feb 25, 2020
025,00050,00075,000100,000SHARES HELD
Trading cadence · quarterly flow
BUY ● SELL ●
2020
FLOW · 2 buys / 0 sellsCOVERAGE · 1 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILED
SGMO
SANGAMO THERAPEUTICS, INC
PURCHASEGRANT
Stock grant
100,000——100,000Feb 25, 2020Feb 26, 2020 ↗
SGMO
SANGAMO THERAPEUTICS, INC
PURCHASEGRANT
Stock grant
50,000——50,000Feb 25, 2020Feb 26, 2020 ↗
Other insiders · SGMO
Loading peer insiders…
About this filer
CIK 0001765497
ROLE
EVP Research & Development
PRIMARY
SGMO
COMPANIES
1
ACTIVE SINCE
Feb 2020
MARKETPEEL · /INSIDER/0001765497DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

The morning brief, before the bell.

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback